600513.SS · 联环药业
China A-shares · RS rating 41 · As of 2026-10-14
| Price | 14.91 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 65 / 65 / 32 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 23 / 26 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -6.2% |
| Distance from 52-week high | +51.5% |
| Market cap (USD) | $708.7M |